We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WISE:LSEWise PLC Class A Analysis

Data as of 2026-03-14 - not real-time

£885.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Wise plc trades at GBP 885.5, roughly 31% below its DCF‑derived fair value of GBP 989.6, indicating a material upside. The stock sits just above a key support level around GBP 824 while the 20‑day SMA (869.4) is also below the current price, suggesting limited immediate downside. Technical momentum is mixed: the RSI sits near the mid‑range at 51, the MACD histogram is positive (4.06) and the signal line is bearish, and volume trends are decreasing, all pointing to a short‑term bearish bias despite a bullish histogram. Volatility is elevated at over 30% (30‑day) and beta is low (0.31), meaning price swings are pronounced but the stock is less sensitive to market moves.
Fundamentally, Wise delivers robust growth with 9.2% revenue expansion, high gross margins (~80%) and operating margins (~27%), and a strong cash position (≈£1.58 bn) versus modest debt (£0.30 bn). ROE is healthy at 29.7%, free cash flow exceeds £0.43 bn, and the company carries no dividend obligations, reinforcing its capacity to reinvest. Compared with an industry PE average of ~33.7, Wise’s PE of ~23.9 is attractive, supporting an undervalued classification and a long‑term growth narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price hovering just above support
  • decreasing volume indicating waning momentum
  • mixed MACD signals with bullish histogram but bearish trend

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • significant upside to DCF fair value
  • strong revenue growth and high profitability margins
  • low debt and ample cash generation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • sustainable high margins and cash flow conversion
  • global expansion potential in cross‑border payments
  • low beta and defensive balance sheet supporting resilience

Key Metrics & Analysis

Financial Health

Revenue Growth9.20%
Profit Margin22.49%
P/E Ratio23.9
ROE29.67%
ROA1.66%
Debt/Equity21.04
P/B Ratio634.8
Op. Cash Flow£5.3B
Free Cash Flow£429.3M
Industry P/E33.7

Technical Analysis

TrendBearish
RSI51.3
Support£824.50
Resistance£933.00
MA 20£869.38
MA 50£885.24
MA 200£976.76
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88

Valuation

Fair Value£989.63
Target Price£1,161.63
Upside/Downside31.18%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.32
Volatility30.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.